Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

Human Microbiome

Nemesis Bioscience awarded €2m EIC accelerator grant

19th July 2022

Nemesis Bioscience Ltd announced today that it has been awarded a European Innovation Council (EIC) Accelerator grant of €2 million to advance its work in the prevention of antibiotic-resistant infections.
Dr Yoshinori Yamano

Nemesis bioscience announces the appointment of Dr Yoshinori Yamano as non-executive director

15th July 2022

Nemesis Bioscience Ltd announced today that it had appointed Dr Yoshinori Yamano to its board as a non-executive director.
biomaterials

Zentraxa announce seed financing to progress their platform technology for precision biomaterials

27th May 2022

Zentraxa are excited to announce capital investment from Future Planet Capital, Bristol Private Equity Club (BPEC) and Science Angel Syndicate to develop their innovative Zentide…
Alzheimer’s

Infinity BiologiX and Cytox collaborate to provide new genetic test to predict the risk of cognitive decline due to Alzheimer’s disease

23rd June 2021

Powered by Cytox’s genoSCORE, the new test enables physicians to support patients with lifestyle changes, and guide possible use of drug therapy…
Brain

Cytox launches genoSCORE-LAB test to predict the risk of developing Alzheimer’s disease

28th February 2021

Non-invasive genetic test enables physicians to assess an individual’s risk of cognitive decline due to Alzheimer’s from a simple saliva sample provided from home.
Research collaboration with Shionogi

Nemesis Bioscience announces research collaboration with Shionogi

6th July 2020

Announced today that it had reached an agreement on terms for a two-year research collaboration with Shionogi & Co. Ltd. to further develop Nemesis Transmid Technology© for the treatment…
ATELERIX LTD

Atelerix and Perfectus Biomed Group collaborate to improve the storage of COVID-19 test swabs

22nd June 2020

The UK Innovation and Science Seed Fund (UKI2S) is delighted to announce the collaboration of Atelerix and Perfectus Biomed Group, two of UKI2S’s portfolio companies.
Coins

Funding future innovations – UKI2S speaks to OBN

22nd April 2020

UKI2S provides its insights into early stage investment for life science companies and the key things investors are looking for.
ATELERIX LTD

Meet the rising stars of the biotech sector at Genesis 2019

3rd December 2019

At this year’s Genesis Conference, Oliver Sexton, Investment Director at UKI2S, will be introducing some of the brightest and best rising stars of the biotech industry.
Meeting

Policy leaders share ambitious vision for increased R&D investment post-election

27th November 2019

With the General Election now well-underway and the main party manifestos published, what is the policy outlook for science and technology in the next Parliament?
ATELERIX LTD

Sanj Kumar joins Atelerix as Chief Business Officer

19th November 2019

Cambridge and Newcastle, UK – Atelerix, pioneers in the storage and transport of cells at room temperature, announced today that it has significantly expanded…
UKI2S win OBN award

OBN Awards Winner Announcement – UKI2S

8th November 2019

UK Innovation & Science Seed Fund (UKI2S) is delighted to announce it is has been awarded ‘Best Sector Support Organisation’ at the 11th Annual OBN Awards celebration last night.
Growth and money

Medical device company C-Major Medical secures equity investment

7th October 2019

C-Major Medical, a medical device product development company based at Sci-Tech Daresbury, using its innovative technology platform to radically reduce the number of needle stick injuries (NSI’s) globally…
Medication

Procarta receives carb-x award of up to $9.2 million

17th September 2019

Procarta Biosystems, a privately held UK-based biotech company, today announced a CARB-X award of up to $9.2 million to progress its pipeline of antibiotic precision medicines.
Medication

The NHS leads the way with world’s first drug ‘subscription’ scheme to tackle global antimicrobial resistance crisis

5th September 2019

Having saved millions of lives across the planet, antibiotics are beginning to fail us: indiscriminate use in humans and animals has led to a crisis of drug resistant infections.

ATELERIX LTD

Atelerix Consortium Awarded £267,000 Innovate UK Grant for collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies

21st August 2019

Atelerix, pioneers in the storage and transport of cells at room temperature, today announces that it has been awarded a grant of £267,000…
David Lawrence UKI2S

Sharing the Secrets of Start-up Success

20th August 2019

Small companies are better than big businesses at maintaining a culture of innovation. David Lawrence from the UK Innovation and Science Seed Fund explores the secrets to their success and discusses how venture capitalists identify start-ups with potential.
seedling

Supporting start-ups to maximise success for both the company and the industry

6th August 2019

After a busy year so far, the summer lull is the time for a much-needed holiday, as well as offering the chance to get on top of the growing pile of admin on my desk.

Lab work

SynbiCITE’s 4-day MBA: Advancing the next generation of engineering biology companies

29th July 2019

SynbiCITE, the UK’s national centre for the commercialisation of engineering biology, is powering the engineering biology industry, applying lab-based R&D…
Discussion on technology & innovation at SynbiTECH 2019

SynbiTECH 2019: Innovation, Investment and the Engineering Biology Revolution

17th July 2019

Oliver Sexton, Investment Director, and Pablo Lubroth, Investment Manager, UKI2S, share their thoughts on the recent SynbiTECH2019 conference in London.
Mark White

Can SME’s work with utilities and find a way to market?

4th July 2019

Engineering technology innovators Oxford Flow and Utonomy are testing new products to improve the gas distribution network.
Andrew Muir

BBSRC Awards bust the UK’s innovation myth

25th June 2019

The UK is good at research, but poor at innovation. That’s a common view among policymakers, but an out-dated one, argues Andy Muir from the UK Innovation & Science Seed Fund who recently judged…
Trophy

Crescendo Biologics wins in “Life Science Innovation” category at the Business Weekly Awards 2019

22nd March 2019

The drug developer of novel, targeted T-cell enhancing therapeutics, announces winning the award for “Life Science Innovation” at the Business Weekly Awards 2019.
DNA

Life, but not as you know it

25th February 2019

The DNA alphabet just doubled in size. Steven Benner at the Foundation for Applied Molecular Evolution in Florida has published two new functional, artificial nucleobases.
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.